PID is an infection of the female reproductive organs—most often the uterus, fallopian tubes, and ovaries—typically caused by untreated STIs such as chlamydia or gonorrhea. If left unaddressed, PID can result in chronic pelvic pain, infertility, or ectopic pregnancy. Its symptoms can be mild or absent, making early detection difficult. PID is most prevalent among women aged 15–24 and globally affects around one in eight sexually active young women.
Pelvic inflammatory disease is a bacterial infection of the upper reproductive tract, commonly caused by Chlamydia trachomatis or Neisseria gonorrhoeae, which ascend from the cervix or vagina into the uterus, tubes, and ovaries. Symptoms may include lower abdominal or pelvic pain, unusual vaginal discharge, discomfort during intercourse, fever, and irregular menstrual bleeding.
However, many cases are asymptomatic, which delays diagnosis. If untreated, PID may lead to severe complications, including infertility, ectopic pregnancies, chronic pelvic discomfort, and pelvic abscesses. Diagnosis is clinical—based on history and exam—with support from ultrasound or lab tests. Treatment relies on early broad-spectrum antibiotics; surgery may be required in complicated cases. Preventive strategies include safe sex, routine STI testing, and early treatment.
Pelvic Inflammatory Disease (PID) arises when bacteria spread upward from the vagina or cervix. This typically involves:
Other contributors include:
You may be at higher risk if you:
Left untreated or recurrent, PID can result in:
Prompt broad-spectrum antibiotics targeting gonorrhea, chlamydia, and anaerobic bacteria are essential. Standard therapy includes ceftriaxone, doxycycline, and metronidazole. Severe cases or abscesses may require hospitalization.
Partners should also receive treatment to prevent reinfection. Medication only advised under medical supervision.
MASSH PROLIFE leads in PID care through advanced minimally invasive and single-incision laparoscopic methods. With enhanced visualization and sterile protocols, surgeries are precise and cosmetically discreet, facilitating fast recoveries. Beyond the medical treatment, our holistic care model includes emotional support, fertility preservation, and preventive guidance. We deliver comprehensive care—diagnostic accuracy, timely treatment, and long-term follow-up—tailored to your needs.
MASSH Group of Hospitals is a trusted name in delivering advanced healthcare solutions with a network of premier super speciality hospitals, committed to providing ethical, compassionate, and innovative care. Our expanding network ensures that cutting-edge medical services are always within your reach.
An infection of the female reproductive tract—uterus, tubes, ovaries—primarily from STIs.
Mostly from C. trachomatis and N. gonorrhoeae. Also linked to other bacteria or after procedures like IUD insertion.
Pelvic pain, abnormal discharge, sex pain, fever, painful urination, and irregular bleeding. Many cases present subtly.
Through pelvic exams, STI testing, inflammatory blood tests, imaging, and sometimes laparoscopy.
Yes—early antibiotics cure most cases. Delayed care risks severe outcomes.
Yes. Damage to reproductive organs may impair fertility or increase ectopic pregnancy risk.
With antibiotics, and in severe cases or abscess formation, laparoscopic drainage may be necessary.
Yes. Prior infection increases recurrence risk, particularly without full treatment or ongoing STI exposure.
Use condoms, get routine STI screenings, limit sexual partners, and treat infections promptly.
Avoid intercourse until both you and your partner complete treatment and symptoms have resolved.